Intellectual property rights are a general incentive provided by governments to promote innovation in all fields. In respect of public health, they are embedded in a set of other incentives which influence the pattern of innovation.
Initial reactions to the the report were mixed. According to Bridges Weekly Trade Digest, disagreements among the commission's ten members, who included representatives from industry, government, and academia, delayed publication of the report and resulted in a separate section containing individual commission members' assorted reservations about its content. Although the report explains to some extent why IP protections alone are not sufficient incentive to ensure the satisfaction of certain public health needs in developing countries, critics charge that it fails to provide a more comprehensive analysis of IP's effects on those needs -- and thus, to make more systemic policy recommendations. Others say that the study will encourage more concrete discussions on the topic.A competing report from the International Policy Network was released on March 28, 2006 with one of its lead authors concluding that When it comes to medicines for the diseases of poverty, governmentsare the main barriers to access and innovation. Intellectual property is animportant driver of innovation but in poor countries governments currentlyprevent people from accessing cheap, generic medicines that could cure many ofthe diseases they face. In such circumstance, what is the point of producing newdrugs for these diseases? Governments must remove the taxes, tariffs andregulations that prevent the sick from getting treatment.